The role of rosiglitazone in the proliferation of vascular smooth muscle cells after experimental subarachnoid hemorrhage

[1] Chen S(2014)Controversies and evolving new mechanisms in subarachnoid hemorrhage Prog Neurobiol 115 64-91

[2] Feng H(2005)Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment Pharmacol Ther 105 23-56

[3] Sherchan P(2003)Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage Stroke 34 427-433

[4] Klebe D(2006)Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy Neurocrit Care 5 215-221

[5] Zhao G(2011)Mitogen-activated protein kinases in cerebral vasospasm after subarachnoid hemorrhage: a review Acta Neurochir Suppl 110 133-139

[6] Sun X(2008)New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage Drug Discov Today 13 254-260

[7] Zhang J(2008)The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage Neurocrit Care 8 404-412

[8] Tang J(2011)Therapeutic potential of peroxisome proliferator-activated receptor gamma agonist rosiglitazone in cerebral vasospasm after a rat experimental subarachnoid hemorrhage model J Neurol Sci 305 85-91

[9] Zhang JH(2010)Activation of peroxisome proliferator-activated receptor γ in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema Neuropharmacology 58 337-345

[10] Pluta RM(2001)Caveolin-1 expression negatively regulates cell cycle progression by inducing G0/G1 arrest via a p53/p21WAF1/Cip1-dependent mechanism Mol Biol Cell 12 2229-2244

[1] Chen S(2014)Controversies and evolving new mechanisms in subarachnoid hemorrhage Prog Neurobiol 115 64-91

[2] Feng H(2005)Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment Pharmacol Ther 105 23-56

[3] Sherchan P(2003)Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage Stroke 34 427-433

[4] Klebe D(2006)Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy Neurocrit Care 5 215-221

[5] Zhao G(2011)Mitogen-activated protein kinases in cerebral vasospasm after subarachnoid hemorrhage: a review Acta Neurochir Suppl 110 133-139

[6] Sun X(2008)New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage Drug Discov Today 13 254-260

[7] Zhang J(2008)The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage Neurocrit Care 8 404-412

[8] Tang J(2011)Therapeutic potential of peroxisome proliferator-activated receptor gamma agonist rosiglitazone in cerebral vasospasm after a rat experimental subarachnoid hemorrhage model J Neurol Sci 305 85-91

[9] Zhang JH(2010)Activation of peroxisome proliferator-activated receptor γ in brain inhibits inflammatory pain, dorsal horn expression of Fos, and local edema Neuropharmacology 58 337-345

[10] Pluta RM(2001)Caveolin-1 expression negatively regulates cell cycle progression by inducing G0/G1 arrest via a p53/p21WAF1/Cip1-dependent mechanism Mol Biol Cell 12 2229-2244